Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Macy's Inc (M) vs Sanofi SA (SNY) Price & Performance

Macy's IncTrade

Price performance (Past 24H)

Key statistics

Macy's Inc vs Sanofi SA — how do they compare? Macy's Inc trades at $24.53 (market cap $6.45B), while Sanofi SA trades at $43.56 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 16.2× Macy's Inc's market cap, and Sanofi SA pays the higher dividend (5.55%). Which is the better fit depends on your goals.

MSNY
Market Cap
$6.45B$104.30B
Sector
Consumer CyclicalHealth
52-Week High
$26.21$52.34
52-Week Low
$12.73$41.33
Enterprise Value
$10.26B$124.19B
Dividend Yield
3.12%5.55%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Macy's Inc

Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.

Read more on M

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY